Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Ingle

Showing results (21-30 of 162) with videos related to

Pageof 17
Sort By:
Cancer|January 1, 1977
Bone marrow involvement in breast cancer: effect on response and tolerance to combination chemotherapyJ N Ingle, D C Tormey, J M Bull, et al.
American Journal of Clinical Oncology|October 1, 1986
Evaluation of bisantrene administered by 72-hour infusion in women with metastatic breast cancerJ N Ingle, H J Long, A J Schutt, et al.
American Journal of Clinical Oncology|April 1, 1989
A prospective, randomized controlled trial of megestrol acetate among high-risk patients with resected malignant melanomaE T Creagan, J N Ingle, A J Schutt, et al.
Cancer Treatment Reports|November 1, 1979
Phase II evaluation of maytansine in patients with advanced head and neck cancerE T Creagan, T R Fleming, J H Edmonson, et al.
American Journal of Clinical Oncology|October 1, 1989
Evaluation of menogaril in patients with metastatic sarcomas and no prior chemotherapy exposureJ C Buckner, J H Edmonson, J N Ingle, et al.
Cancer|April 1, 1982
Phase II study of high-dose tamoxifen (NSC-180973) in patients with disseminated malignant melanomaE T Creagan, J N Ingle, D L Ahmann, et al.
Cancer Treatment Reports|November 1, 1983
Phase II clinical trial of L-alanosine in advanced upper aerodigestive cancerE T Creagan, A J Schutt, J N Ingle, et al.
Head & Neck Surgery|July 1, 1984
A phase II study of cis-diamminedichloroplatinum and 5-fluorouracil in advanced upper aerodigestive neoplasmsE T Creagan, J N Ingle, A J Schutt, et al.
Mayo Clinic Proceedings|August 11, 1991
Systemic adjuvant therapy in women with resected node-negative breast cancerL C Hartmann, R F Marschke, D J Schaid, et al.
Cancer|February 1, 1996
A randomized trial of megestrol acetate with or without premarin in the treatment of potentially responsive metastatic breast cancer. A Study of the Eastern Cooperative Oncology Group (E2185)C D Cobau, K Declercq, D Neuberg, et al.
Pageof 17

Showing results (21-30 of 162) with videos related to

Sort By:
Pageof 17
Cancer|January 1, 1977
Bone marrow involvement in breast cancer: effect on response and tolerance to combination chemotherapyJ N Ingle, D C Tormey, J M Bull, et al.
American Journal of Clinical Oncology|October 1, 1986
Evaluation of bisantrene administered by 72-hour infusion in women with metastatic breast cancerJ N Ingle, H J Long, A J Schutt, et al.
American Journal of Clinical Oncology|April 1, 1989
A prospective, randomized controlled trial of megestrol acetate among high-risk patients with resected malignant melanomaE T Creagan, J N Ingle, A J Schutt, et al.
Cancer Treatment Reports|November 1, 1979
Phase II evaluation of maytansine in patients with advanced head and neck cancerE T Creagan, T R Fleming, J H Edmonson, et al.
American Journal of Clinical Oncology|October 1, 1989
Evaluation of menogaril in patients with metastatic sarcomas and no prior chemotherapy exposureJ C Buckner, J H Edmonson, J N Ingle, et al.
Cancer|April 1, 1982
Phase II study of high-dose tamoxifen (NSC-180973) in patients with disseminated malignant melanomaE T Creagan, J N Ingle, D L Ahmann, et al.
Cancer Treatment Reports|November 1, 1983
Phase II clinical trial of L-alanosine in advanced upper aerodigestive cancerE T Creagan, A J Schutt, J N Ingle, et al.
Head & Neck Surgery|July 1, 1984
A phase II study of cis-diamminedichloroplatinum and 5-fluorouracil in advanced upper aerodigestive neoplasmsE T Creagan, J N Ingle, A J Schutt, et al.
Mayo Clinic Proceedings|August 11, 1991
Systemic adjuvant therapy in women with resected node-negative breast cancerL C Hartmann, R F Marschke, D J Schaid, et al.
Cancer|February 1, 1996
A randomized trial of megestrol acetate with or without premarin in the treatment of potentially responsive metastatic breast cancer. A Study of the Eastern Cooperative Oncology Group (E2185)C D Cobau, K Declercq, D Neuberg, et al.
Pageof 17